eGenesis

August 22, 2017

Exploring the History & Viability of Xenotransplantation: Porcine Retroviruses, CRISPR Off-Target Effects, Immune Rejection & Regulatory Hurdles

[vc_row][vc_column][vc_column_text]Scientists at e-Genesis, a Massachusetts-based biotech firm, recently announced that they have successfully utilised CRISPR gene-editing technology to inactivate Porcine Endogenous Retroviruses (PERVs) in a line […]